 
Vaccines & Gene Therapies
GMP production of vaccines and gene therapeutics for clinical trials is offered from
2 – 100 liters. Downstream processing using column chromatography is standard using a fully disposable system. The production of viruses classically propagated in chicken eggs is also a core specialty of Vivalis through the use of our EB66® cell line. Visit www.vivalis.com to learn more about EB66® cells and their use in virus production.
Services include:
• GMP master cell banks and working cell banks • GMP master virus banks • Process development and optimization • Non-GMP (research grade) bulk API production • GMP vaccine production and virus production up to 100 L • Continuous quality assurance and regulatory support |
|
| Go to Vivalis corporate web site | Vivalis - From cells to therapeutics | Copyright © 1999-2011 Vivalis. All rights reserved. | Legal notice |
